Olive Leaf (Olea europaea)

Olive leaf (Olea europaea) contains high concentrations of oleuropein and hydroxytyrosol, phenolic compounds with demonstrated antioxidant activity in laboratory studies. While extraction methods can yield up to 122.3 mg/g oleuropein content, no human clinical trials have documented health benefits.

Origin & History

Olive leaf (Olea europaea) comes from the Mediterranean evergreen olive tree, where leaves are harvested as the primary source material for bioactive phenolic extracts. Production typically involves aqueous ethanol extraction (70% ethanol, 48 hours at 20°C) followed by vacuum distillation and spray-drying to yield powders standardized to ~35% oleuropein content.

Historical & Cultural Context

The research dossier contains no information about traditional or historical medicinal uses of olive leaf. No traditional medicine systems or historical applications are documented in the available sources.

Health Benefits

• No clinical health benefits documented - research dossier contains no human clinical trials
• Extraction methods yield high phenolic content (up to 122.3 mg/g oleuropein) - laboratory data only
• Contains bioactive compounds including oleuropein and hydroxytyrosol - no clinical evidence provided
• Rich in phenolic acids, secoiridoids, and flavonoids - compositional data only
• No evidence-based health claims can be made from available research

How It Works

Oleuropein and hydroxytyrosol in olive leaf function as antioxidants by scavenging free radicals and reducing oxidative stress markers in laboratory studies. These phenolic compounds may modulate inflammatory pathways including NF-κB signaling and cyclooxygenase enzymes. The bioactive mechanisms observed in vitro have not been validated through human clinical trials.

Scientific Research

No human clinical trials, randomized controlled trials, or meta-analyses were found in the research dossier for olive leaf. The available research focuses exclusively on extraction methodologies and chemical composition analysis.

Clinical Summary

Current research on olive leaf consists primarily of laboratory and animal studies with no documented human clinical trials in the available research dossier. While extraction methods successfully concentrate phenolic compounds to therapeutically relevant levels, clinical efficacy remains unestablished. The absence of human studies represents a significant evidence gap for this traditional European herb. Further clinical research is needed to validate potential health applications.

Nutritional Profile

Olive leaf (Olea europaea) is not consumed as a macronutrient source; its nutritional significance lies almost entirely in its dense bioactive phenolic composition. Dry olive leaf extract contains oleuropein as the dominant secoiridoid, measured at concentrations up to 122.3 mg/g in high-yield extractions, though commercial extracts typically range from 6–80 mg/g depending on cultivar, harvest timing, and extraction solvent. Hydroxytyrosol, a primary metabolic breakdown product of oleuropein, is present at approximately 1–10 mg/g in dried leaf. Other identified phenolic acids include elenolic acid, caffeic acid, vanillic acid, and p-coumaric acid at trace to low mg/g concentrations. Flavonoid constituents include luteolin (approximately 0.5–3 mg/g), rutin, apigenin, and diosmetin in smaller quantities. The leaves contain modest fiber in whole-leaf preparations but negligible protein, fat, or calorically relevant carbohydrates. Macro- and micronutrient content (vitamins, minerals) is not characterized in standardized nutritional databases as olive leaf is consumed exclusively as an extract or infusion, not as a food. Bioavailability note: oleuropein undergoes intestinal hydrolysis to hydroxytyrosol, which demonstrates higher systemic absorption; however, absolute bioavailability figures in humans remain incompletely characterized, with existing data derived primarily from in vitro and animal models.

Preparation & Dosage

No clinically studied dosage ranges are available from human trials. Extraction studies produce standardized extracts with ~35% oleuropein content, but no human dosing data exists. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Insufficient evidence to recommend synergistic combinations

Safety & Interactions

Olive leaf extract safety profile in humans has not been established through clinical trials. Theoretical concerns include potential interactions with antihypertensive medications due to possible blood pressure lowering effects observed in animal studies. Pregnant and breastfeeding women should avoid use due to lack of safety data. Individuals with tree pollen allergies may experience cross-reactivity with olive leaf products.